Search research articles
Contact Us
Filters
Showing results (101-110 of 124) with videos related to
Page
of 13
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
May 5, 2026
Mast Cells and Endothelial Cells Mediate Interleukin-33 and ST2 Responses in Distal COPD Lungs
Cecilia K Andersson, Premkumar Siddhuraj, Jimmie Jönsson, et al.
Immunity
|
April 10, 2020
Interleukin-33 Signaling Controls the Development of Iron-Recycling Macrophages
Yuning Lu, Gemma Basatemur, Ian C Scott, et al.
Clinical Pharmacology and Therapeutics
|
December 20, 2023
A Randomized Phase I Study of the Anti-Interleukin-33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease
Fred Reid, Dave Singh, Muna Albayaty, et al.
Nature Communications
|
December 5, 2023
Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine
Ryan S Thwaites, Ashley S S Uruchurtu, Victor Augusti Negri, et al.
Nature Communications
|
February 21, 2020
REEP5 depletion causes sarco-endoplasmic reticulum vacuolization and cardiac functional defects
Shin-Haw Lee, Sina Hadipour-Lakmehsari, Harsha R Murthy, et al.
Nature Communications
|
September 26, 2015
Evolutionarily conserved intercalated disc protein Tmem65 regulates cardiac conduction and connexin 43 function
Parveen Sharma, Cynthia Abbasi, Savo Lazic, et al.
The Journal of Allergy and Clinical Immunology
|
April 22, 2026
AZD8630/AMG 104, an inhaled Anti-TSLP antibody fragment, for moderate-to-severe asthma: a phase 1 randomized controlled trial
Sarah R Doffman, Davinder P S Dosanjh, Muhammad Waqas Sadiq, et al.
Plos One
|
October 10, 2019
Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases
Matthew Traylor, Rachel Knevel, Jing Cui, et al.
The Journal of Allergy and Clinical Immunology
|
August 3, 2023
Nasal IL-13 production identifies patients with late-phase allergic responses
Nicholas J Campion, Sergio Villazala-Merino, Ryan S Thwaites, et al.
ERJ Open Research
|
October 23, 2023
A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2
Tom Wilkinson, Anthony De Soyza, Miles Carroll, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 124) with videos related to
Sort By:
Page
of 13
American Journal of Respiratory and Critical Care Medicine
|
May 5, 2026
Mast Cells and Endothelial Cells Mediate Interleukin-33 and ST2 Responses in Distal COPD Lungs
Cecilia K Andersson, Premkumar Siddhuraj, Jimmie Jönsson, et al.
Immunity
|
April 10, 2020
Interleukin-33 Signaling Controls the Development of Iron-Recycling Macrophages
Yuning Lu, Gemma Basatemur, Ian C Scott, et al.
Clinical Pharmacology and Therapeutics
|
December 20, 2023
A Randomized Phase I Study of the Anti-Interleukin-33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease
Fred Reid, Dave Singh, Muna Albayaty, et al.
Nature Communications
|
December 5, 2023
Early mucosal events promote distinct mucosal and systemic antibody responses to live attenuated influenza vaccine
Ryan S Thwaites, Ashley S S Uruchurtu, Victor Augusti Negri, et al.
Nature Communications
|
February 21, 2020
REEP5 depletion causes sarco-endoplasmic reticulum vacuolization and cardiac functional defects
Shin-Haw Lee, Sina Hadipour-Lakmehsari, Harsha R Murthy, et al.
Nature Communications
|
September 26, 2015
Evolutionarily conserved intercalated disc protein Tmem65 regulates cardiac conduction and connexin 43 function
Parveen Sharma, Cynthia Abbasi, Savo Lazic, et al.
The Journal of Allergy and Clinical Immunology
|
April 22, 2026
AZD8630/AMG 104, an inhaled Anti-TSLP antibody fragment, for moderate-to-severe asthma: a phase 1 randomized controlled trial
Sarah R Doffman, Davinder P S Dosanjh, Muhammad Waqas Sadiq, et al.
Plos One
|
October 10, 2019
Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases
Matthew Traylor, Rachel Knevel, Jing Cui, et al.
The Journal of Allergy and Clinical Immunology
|
August 3, 2023
Nasal IL-13 production identifies patients with late-phase allergic responses
Nicholas J Campion, Sergio Villazala-Merino, Ryan S Thwaites, et al.
ERJ Open Research
|
October 23, 2023
A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2
Tom Wilkinson, Anthony De Soyza, Miles Carroll, et al.
Page
of 13